Reports
Sale
Global Enteric Disease Testing Market Size, Trends, Report: By Technology: Traditional, Rapid; By Applications: Food, Dairy Products, Processed Food, Food and Vegetable; Regional Analysis; Patent Analysis; Grants Analysis; Funding and Investment Analysis; Partnership and Collaborations Analysis Supplier Landscape; 2024-2032
Global Enteric Disease Testing Market Outlook
The global enteric disease testing market size was valued at USD 2.9 billion in 2023, driven by the increasing prevalence of bacterial diseases and viruses across the globe. The market size is anticipated to grow at a CAGR of 4.1% during the forecast period of 2024-2032 to achieve a value of USD 4.2 billion by 2032.
Enteric Disease Testing: Introduction
Diseases that are caused by microorganisms such as bacteria, parasites, and virus through the consumption of contaminated food or water are known as enteric diseases. Enteric disease could be air-borne, thus they are capable of spreading from one person to another. The common symptoms associated with these diseases include vomiting, nausea, diarrhoea, fever, abdominal cramps, chills, and loss of appetite, among others. The symptoms can appear as soon as thirty minutes or within a span of about 7 to 10 days. The official records for the number of cases associated with enteric diseases are not completely accurate because the symptoms are same as flu, and it often takes longer to identify as enteric disease.
Global Enteric Disease Testing Market Analysis
The increasing awareness about consuming safe and clean food and water is primarily driving the growth of the market. People are increasingly focusing on frequent hand washing, eating properly cooked food, and drinking water from reliable sources only, especially after the COVID-19 pandemic. This has also increased the enteric diseases testing market because people have started taking these symptoms more seriously and prefer getting a proper checkup done if the symptoms last longer than three days.
The increasing investments from pharmaceutical companies and research institutions to help in the development of novel therapies for enteric diseases is directly influencing the global enteric disease testing market growth. Additionally, the increasing focus on improved diet intake in the form of balanced diets and health supplements to improve the immune system to fight against such diseases is also aiding the market growth. The rise in demand for the development of vaccines against these enteric viruses is also a major trend. New vaccines with enhanced efficacy for enteric diseases are currently under development and might aid the market growth in the coming years if they attain approval.
Global Enteric Disease Testing Market Segmentations
Market by Technology
- Traditional
- Rapid
Market Breakup by Applications
- Food
- Dairy Products
- Processed Food
- Food and Vegetable
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Enteric Disease Testing Market Overview
The market has been witnessing a substantial rise and is expected to continue growing gradually. Factors such as rising prevalence of bacterial diseases and viruses, including gastroenteritis, food poisoning, and infections, caused by pathogens such as Salmonella, E.coli, and norovirus, are significantly driving the enteric disease testing market growth. There has been a substantial awareness about enteric diseases among governments which is resulting in various educational initiatives and campaigns by healthcare organizations with the support of government has helped creating awareness about the impact of enteric diseases and how to prevent it. Such initiatives are directly contributing to the growth of the market.
Enteric Disease Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Biomerica, Inc.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Cepheid (Danaher Corporation)
- CorisBioconcept SPRL
- DiaSorin S.p.A.
- Meridian Bioscience, Inc.
- Quest Diagnostics Incorporated
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Enteric Disease Testing Market Overview
3.1 Global Enteric Disease Testing Market Historical Value (2017-2023)
3.2 Global Enteric Disease Testing Market Forecast Value (2024-2032)
4 Global Enteric Disease Testing Market Landscape
4.1 Global Enteric Disease Testing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Enteric Disease Testing: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Enteric Disease Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Enteric Disease Testing Market Segmentation
6.1 Global Enteric Disease Testing Market by Technology
6.1.1 Market Overview
6.1.2 Traditional
6.1.3 Rapid
6.2 Global Enteric Disease Testing Market by Applications
6.2.1 Market Overview
6.2.2 Food
6.2.3 Dairy Products
6.2.4 Processed Food
6.2.5 Food and Vegetable
6.3 Global Enteric Disease Testing Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Global Enteric Disease Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Global Enteric Disease Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Global Enteric Disease Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Global Enteric Disease Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Global Enteric Disease Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton, Dickinson and Company (BD)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Biomerica, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 bioMérieux SA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cepheid (Danaher Corporation)
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 CorisBioconcept SPRL
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 DiaSorin S.p.A.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Meridian Bioscience, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Quest Diagnostics Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2.9 billion in 2023, driven by the increasing demand for minimally invasive diagnosis procedures.
The market is anticipated to grow at a CAGR of 4.1% during the forecast period of 2024-2032, likely to reach a market value of USD 4.2 billion by 2032.
The rising prevalence of bacterial diseases and viruses is a major factor driving the market growth.
The increasing investments from pharmaceutical companies and research institutions to find new testing methods and appropriate drugs is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The testing market uses traditional and rapid technologies.
They find wide applications in food, dairy products, processed food, food and vegetable.
Key players involved in the market are Abbott Laboratories, Becton, Dickinson and Company (BD), Biomerica, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid (Danaher Corporation), CorisBioconcept SPRL, DiaSorin S.p.A., Meridian Bioscience, Inc., and Quest Diagnostics Incorporated.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER